For the past 12 years, CHI’s Immuno-Oncology Summit has grown into the premier annual meeting for advancing biotherapeutics. This summit offers a comprehensive 3-day, 6-track program, exploring bi- and multi-specific biotherapeutics, highlighting the latest developments in CAR T therapies, emerging targeting technologies, personalized immunotherapy, cell-based immunotherapies, and addressing the challenges of overcoming tumor resistance. Attendees delve into predictive models, tumor microenvironment modulation, and the increasing role of AI and machine learning in cancer immunology. The summit serves as a vital platform for exchanging high-quality research and fostering collaboration in the ever-evolving landscape of immuno-oncology.
Every year, 375+ thought leaders and influencers from industry and academia converge to showcase the latest breakthroughs in cancer immunology. Beyond the enriching discussions, the dynamic venue fosters extensive networking and collaborative opportunities, empowering teams to focus on their objectives.
We look forward to seeing you in Philadelphia this August 7th-9th where we convene to advance our understanding of the immune system, propelling the development of next-generation immunotherapies to optimize patient treatment outcomes.